Raras
Buscar doenças, sintomas, genes...
Aceruloplasminemia
ORPHA:48818CID-10 · E83.1CID-11 · 3A00.YOMIM 604290DOENÇA RARA

Distúrbio de neurodegeneração com acúmulo de ferro no cérebro (NBIA) de início na idade adulta, caracterizado por anemia, degeneração da retina, diabetes e vários sintomas neurológicos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Distúrbio de neurodegeneração com acúmulo de ferro no cérebro (NBIA) de início na idade adulta, caracterizado por anemia, degeneração da retina, diabetes e vários sintomas neurológicos.

Pesquisas ativas
1 ensaio
2 total registrados no ClinicalTrials.gov
Publicações científicas
258 artigos
Último publicado: 2026 Jan 5

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.1
Japan
Início
Adult
+ elderly
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E83.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
9 sintomas
👁️
Olhos
4 sintomas
🫃
Digestivo
4 sintomas
🩸
Sangue
3 sintomas
💪
Músculos
2 sintomas
🫘
Rins
1 sintomas

+ 25 sintomas em outras categorias

Características mais comuns

90%prev.
Anormalidade do sistema nervoso
Muito frequente (99-80%)
90%prev.
Aceruloplasminemia
Muito frequente (99-80%)
90%prev.
Atividade anormal de enzima/coenzima
Muito frequente (99-80%)
90%prev.
Aumento da concentração circulante de ferritina
Muito frequente (99-80%)
90%prev.
Anemia refratária
Muito frequente (99-80%)
90%prev.
Anemia microcítica hipocrômica
Muito frequente (99-80%)
50sintomas
Muito frequente (6)
Frequente (16)
Ocasional (17)
Muito raro (2)
Sem dados (9)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 50 características clínicas mais associadas, ordenadas por frequência.

Anormalidade do sistema nervosoAbnormality of the nervous system
Muito frequente (99-80%)90%
Aceruloplasminemia
Muito frequente (99-80%)90%
Atividade anormal de enzima/coenzimaAbnormal enzyme/coenzyme activity
Muito frequente (99-80%)90%
Aumento da concentração circulante de ferritinaIncreased circulating ferritin concentration
Muito frequente (99-80%)90%
Anemia refratáriaRefractory anemia
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico258PubMed
Últimos 10 anos102publicações
Pico202214 papers
Linha do tempo
2026Hoje · 2026🧪 2012Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

CPCeruloplasminDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Multifunctional blue, copper-binding (6-7 atoms per molecule) glycoprotein. It has ferroxidase activity oxidizing Fe(2+) to Fe(3+) without releasing radical oxygen species. It is involved in iron transport across the cell membrane (PubMed:16150804). Copper ions provide a large number of enzymatic activites. Oxidizes highly toxic ferrous ions to the ferric state for further incorporation onto apo-transferrins, catalyzes Cu(+) oxidation and promotes the oxidation of biogenic amines such as norepin

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Aceruloplasminemia

An autosomal recessive disorder of iron metabolism characterized by iron accumulation in the brain as well as visceral organs. Clinical features consist of the triad of retinal degeneration, diabetes mellitus and neurological disturbances.

OUTRAS DOENÇAS (1)
aceruloplasminemia
HGNC:2295UniProt:P00450

Variantes genéticas (ClinVar)

317 variantes patogênicas registradas no ClinVar.

🧬 CP: NC_000003.12:g.149162182G>A ()
🧬 CP: NM_032383.5(HPS3):c.2995C>T (p.Arg999Ter) ()
🧬 CP: NM_000096.4(CP):c.2795_2796del (p.Asp932fs) ()
🧬 CP: NM_000096.4(CP):c.1043del (p.Leu348fs) ()
🧬 CP: NM_000096.4(CP):c.2309_2316dup (p.Phe773fs) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
1Fase 11
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Aceruloplasminemia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

2 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

📖Melhor nível de evidência: Revisão
Timeline de publicações
105 papers (10 anos)
#1

Unexplained Coexisting Injury of the Liver, Pancreas, and Brain.

Gastroenterology2026 Jan 05
#2

[Neurodegeneration Associated with Metal Metabolism].

Brain and nerve = Shinkei kenkyu no shinpo2025 May

Neurodegeneration with brain iron accumulation (NBIA) comprises a heterogeneous group of inherited neurodegenerative disorders collectively characterized by extrapyramidal movement disorders and abnormal iron accumulation in the nuclei of the deep basal ganglia of the brain. Ten NBIA genes have been identified. Aceruloplasminemia is a type of NBIA associated with copper metabolism. Ceruloplasmin contains 95% of the copper in human serum and plays an important role in iron efflux from mammalian cells. The relationship between ceruloplasmin and neurodegenerative diseases was revealed by a decrease in the serum ceruloplasmin concentration, which is characteristic of hepatolenticular degeneration with copper overload, in patients with Wilson's disease. Serum ceruloplasmin levels are typically decreased in patients with Wilson's disease, Menkes's disease (copper deficiency), and aceruloplasminemia. The molecular pathogenesis underlying different forms of neurodegeneration has provided new insights into the pathways of brain iron and copper metabolism.

#3

Teaching NeuroImage: Clinicoradiologic Clues in Aceruloplasminemia.

Neurology2025 Jul 22
#4

Neurodegeneration With Brain Iron Accumulation and Ferroptosis Disorders in Children and Adults: An Imaging Review.

Journal of neuroimaging : official journal of the American Society of Neuroimaging2025

Neurodegeneration with brain iron accumulation (NBIA) refers to a group of rare genetic disorders characterized by abnormal iron deposition in the basal ganglia and brainstem due to impaired iron homeostasis. Disease severity and manifestations vary according to the underlying genetic mutation and age of presentation; however, most subtypes share progressive neurological features such as dystonia, Parkinsonism, spasticity, cognitive decline, and intellectual disability. In this review, we first outline the physiological role of iron in the central nervous system, emphasizing its importance for neurotransmitter synthesis, myelination, and mitochondrial metabolism, and discuss how disruption of homeostatic mechanisms may lead to ferroptosis and neuronal injury. We then explore the role of neuroimaging in the diagnosis of NBIA, with a focus on MRI as the modality of choice. Finally, we provide an overview of the clinical and imaging features of the major NBIA subtypes, highlighting both shared characteristics and distinctive patterns. Covered NBIA include primary disorders of iron metabolism, such as neuroferritinopathy and aceruloplasminemia, and secondary disorders with disrupted iron regulation, including Pantothenate Kinase-Associated Neurodegeneration, Phospholipase A2 Group VI-Associated Neurodegeneration, Mitochondrial Membrane Protein-Associated Neurodegeneration, Beta-Propeller Protein-Associated Neurodegeneration, Fatty Acid Hydroxylase-Associated Neurodegeneration, Coenzyme A Synthetase Protein-Associated Neurodegeneration, Woodhouse-Sakati syndrome, and Kufor-Rakeb Disease. By integrating genetics, pathophysiology, and imaging, this review aims to improve recognition of NBIA and support comprehensive clinical management.

#5

Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases.

Frontiers in physiology2025

Ferroptosis is an iron-dependent programmed cell death that plays an important role in neurodegenerative and neuropsychiatric diseases. In the present study, we have highlighted how different risk factors are involved in the induction of ferroptosis in brain cells. In addition, we also demonstrated how ferroptosis plays an important role in different brain diseases. In our study why we focused and elaborated on the mechanisms of ferroptosis only in brain cells (Neurons, oligodendrocytes, and microglia) because they are particularly vulnerable to such kind of cell death. Additionally, brain cells are more dependent on mitochondrial function, iron regulation, and high levels of polyunsaturated fatty acids (PUFAs) as compared to peripheral body cells. Highlighting ferroptosis is more important because it has demonstrated several important mechanisms of neuronal injury and dysfunction which provides a deep understanding of the etiology of various brain diseases that were not sufficiently described by other programmed cell death pathways. Therefore, it has led to the exploration of new therapeutic strategies against various brain diseases and thus targeting ferroptosis-related proteins opens a new therapeutic window for several incurable brain diseases, and various ferroptosis regulators are now under clinical trials. However, their validation as a preclinical therapeutic agent is needed. Interestingly, here in our study we also summarize the most recent potential therapeutic targets and promising interventions which will provide a beam of light for future therapies against major brain diseases.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC140 artigos no totalmostrando 101

2026

Unexplained Coexisting Injury of the Liver, Pancreas, and Brain.

Gastroenterology
2025

Aceruloplasminemia in two sisters: insights from dopaminergic imaging and a splice-site mutation.

Acta neurologica Belgica
2025

Neurodegeneration With Brain Iron Accumulation and Ferroptosis Disorders in Children and Adults: An Imaging Review.

Journal of neuroimaging : official journal of the American Society of Neuroimaging
2025

Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases.

Frontiers in physiology
2025

MRI R2* and quantitative susceptibility mapping in brain tissue with extreme iron overload.

European radiology experimental
2024

A Novel Mutation Related to Aceruloplasminemia with Mild Clinical Findings: A Case Report.

Reports (MDPI)
2025

Neurodegeneration with Brain Iron Accumulation.

Advances in experimental medicine and biology
2025

Teaching NeuroImage: Clinicoradiologic Clues in Aceruloplasminemia.

Neurology
2025

[Neurodegeneration Associated with Metal Metabolism].

Brain and nerve = Shinkei kenkyu no shinpo
2025

Renal involvement in aceruloplasminemia.

Kidney international
2025

Functional characterisation of missense ceruloplasmin variants and real-world prevalence assessment of Aceruloplasminemia using population data.

EBioMedicine
2025

Aceruloplasminemia as a rare hereditary disease: four case reports in a single center.

Proceedings (Baylor University. Medical Center)
2025

Ceruloplasmin administration in the preclinical mouse model of aceruloplasminemia reveals a sex-related variation in biodistribution.

Communications biology
2024

Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population.

The journal of applied laboratory medicine
2024

Neurodegeneration With Brain Iron Accumulation in a Case of Adult Aceruloplasminemia.

Cureus
2024

Electroconvulsive Therapy in Managing Intractable Psychosis in Hereditary Aceruloplasminemia-Associated Neurodegeneration: A Case Report.

Journal of the Academy of Consultation-Liaison Psychiatry
2024

Simultaneous Occurrence of Wilson's Disease, Autoimmune Hepatitis, and Hereditary Hemochromatosis: A Diagnostic Challenge.

Middle East journal of digestive diseases
2024

A Revised Classification of Primary Iron Overload Syndromes.

Journal of clinical and translational hepatology
2024

Diagnosing aceruloplasminemia: navigating through red herrings.

Annals of hematology
2024

Aceruloplasminemia: Unique Clinical and MRI Findings in a Patient with a Novel Frameshift Mutation.

Movement disorders clinical practice
2024

New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia.

Communications biology
2023

Aceruloplasminemia with Novel Mutation, with IgG4 Related Pachymeningitis - Occam's Razor or Hickam's Dictum?

Annals of Indian Academy of Neurology
2024

Lipid dysmetabolism in ceruloplasmin-deficient mice revealed both in vivo and ex vivo by MRI, MRS and NMR analyses.

FEBS open bio
2023

A Turkish Patient with Aceruloplasminemia Found to Have a Novel Pathogenic Variant Presenting with High Ferritin Level and Microcytic Anemia.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2023

Ceruloplasmin-Deficient Mice Show Dysregulation of Lipid Metabolism in Liver and Adipose Tissue Reduced by a Protein Replacement.

International journal of molecular sciences
2023

Ceruloplasmin-deficient mice show changes in PTM profiles of proteins involved in messenger RNA processing and neuronal projections and synaptic processes.

Journal of neurochemistry
2023

Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant.

Pediatric hematology and oncology
2022

Brain iron accumulation on MRI revealing aceruloplasminemia: a rare cause of simultaneous brain and systemic iron overload.

BJR case reports
2022

Case report: Huppke-Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years.

Frontiers in neurology
2022

Congenital Atypical Microcytic Anemia Accompanied by Hyposideremia and Iron Overload.

Mediterranean journal of hematology and infectious diseases
2022

Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy.

Journal of clinical medicine
2022

Generation of a human induced pluripotent stem cell line NTUHi002-A from a patient with aceruloplasminemia harboring a homozygous splicing mutation c.607+1 delG in CP gene.

Stem cell research
2022

Cerebral Iron Deposition in Neurodegeneration.

Biomolecules
2023

Aceruloplasminemia exhibits typical MRI findings.

Acta neurologica Belgica
2022

A New Pathogenic Missense Variant in a Consanguineous North-African Family Responsible for a Highly Variable Aceruloplasminemia Phenotype: A Case-Report.

Frontiers in neuroscience
2022

Neuroimaging Pearls from the MDS Congress Video Challenge. Part 1: Genetic Disorders.

Movement disorders clinical practice
2022

A case of senile-onset progressive hemiballism and cognitive decline with diffuse brain iron accumulations.

Parkinsonism &amp; related disorders
2022

Dementia as a core clinical feature of a patient with aceruloplasminemia.

Clinical case reports
2022

Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.

Diabetes, metabolic syndrome and obesity : targets and therapy
2021

MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.

NeuroImage
2022

Novel ceruloplasmin gene mutation causing aceruloplasminemia with diabetes in a Chinese woman: a case report.

Annals of palliative medicine
2022

Off-resonance saturation as an MRI method to quantify mineral- iron in the post-mortem brain.

Magnetic resonance in medicine
2022

Aceruloplasminemia: a multimodal imaging study in an Italian family with a novel mutation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Production of Recombinant Human Ceruloplasmin: Improvements and Perspectives.

International journal of molecular sciences
2021

A novel ceruloplasmin mutation identified in a Chinese patient and clinical spectrum of aceruloplasminemia patients.

Metabolic brain disease
2023

ASYMPTOMATIC OCULAR MANIFESTATIONS OF ACERULOPLASMINEMIA IN TWO ADULT WHITE SIBLINGS: A MULTIMODAL IMAGING APPROACH.

Retinal cases &amp; brief reports
2021

Quantification of different iron forms in the aceruloplasminemia brain to explore iron-related neurodegeneration.

NeuroImage. Clinical
2020

Aceruloplasminemia: A Case Report and Review of a Rare and Misunderstood Disorder of Iron Accumulation.

Cureus
2020

Aceruloplasminemia Presenting with Asymmetric Chorea Due to a Novel Frameshift Mutation.

Movement disorders clinical practice
2021

Seizures in Hereditary Aceruloplasminemia.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2020

[Aceruloplasminemia, a rare condition not to be overlooked].

La Revue de medecine interne
2020

Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.

Orphanet journal of rare diseases
2020

New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease.

BMC gastroenterology
2020

Inherited iron overload disorders.

Translational gastroenterology and hepatology
2020

Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.

Internal medicine (Tokyo, Japan)
2020

Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.

International journal of molecular sciences
2020

Intracranial iron distribution and quantification in aceruloplasminemia: A case study.

Magnetic resonance imaging
2020

Different cortical excitability profiles in hereditary brain iron and copper accumulation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2019

Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2020

Hepcidin and its therapeutic potential in neurodegenerative disorders.

Medicinal research reviews
2019

ABSENCE OF MACULAR DEGENERATION IN A PATIENT WITH ACERULOPLASMINEMIA.

Retina (Philadelphia, Pa.)
2019

Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis.

Frontiers in neuroscience
2019

Clinical relevance of heterozygosis for aceruloplasminemia.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2019

Aceruloplasminemia: Neurodegeneration with brain iron accumulation associated with psychosis.

Journal of inherited metabolic disease
2018

Aceruloplasminemia: Waiting for an Efficient Therapy.

Frontiers in neuroscience
2018

Inherited Disorders of Iron Overload.

Frontiers in nutrition
2018

Potential Treatment of Retinal Diseases with Iron Chelators.

Pharmaceuticals (Basel, Switzerland)
2019

[Aceruloplasminemia : Diagnosis and treatment of a rare disease].

Der Nervenarzt
2019

Pathophysiology and classification of iron overload diseases; update 2018.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
2018

Inborn errors of metabolism associated with hyperglycaemic ketoacidosis and diabetes mellitus: narrative review.

Sudanese journal of paediatrics
2018

Rare anemias due to genetic iron metabolism defects.

Mutation research. Reviews in mutation research
2018

Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia.

Handbook of clinical neurology
2018

The interactions between iron and copper in genetic iron overload syndromes and primary copper toxicoses in Japan.

Hepatology research : the official journal of the Japan Society of Hepatology
2019

Does Ceruloplasmin Defend Against Neurodegenerative Diseases?

Current neuropharmacology
2018

Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.

Internal medicine (Tokyo, Japan)
2018

Aceruloplasminemia and putaminal cavitation.

Parkinsonism &amp; related disorders
2018

Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.

Parkinsonism &amp; related disorders
2018

Pancytopenia and Myelodysplastic Changes in Aceruloplasminemia: A Case with a Novel Pathogenic Variant in the Ceruloplasmin Gene.

Internal medicine (Tokyo, Japan)
2018

Current state of knowledge in Chorea-Acanthocytosis as core Neuroacanthocytosis syndrome.

European journal of medical genetics
2018

Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.

EMBO molecular medicine
2017

Extending the aceruloplasminemia phenotype: NBIA on imaging and acanthocytosis, yet only minor neurological findings.

Journal of the neurological sciences
2017

The Resection of Thyroid Cancer Was Associated with the Resolution of Hyporesponsiveness to an Erythropoiesis-stimulating Agent in a Hemodialysis Patient with Aceruloplasminemia.

Internal medicine (Tokyo, Japan)
2017

Radiological Findings of Two Sisters with Aceruloplasminemia Presenting with Chorea.

Clinical neuroradiology
2017

New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients.

Parkinsonism &amp; related disorders
2017

Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2016

A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.

Arquivos de neuro-psiquiatria
2017

Neurodegeneration With Brain Iron Accumulation (NBIA) Syndromes Presenting With Late-Onset Craniocervical Dystonia: An Illustrative Case Series‎.

Movement disorders clinical practice
2016

Aceruloplasminemia With Positive Ceruloplasm Gene Mutation.

JAMA ophthalmology
2017

Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.

Biological trace element research
2016

Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report).

Medicine
2016

Iron chelation in the treatment of neurodegenerative diseases.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
2016

Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans.

Journal of movement disorders
2016

Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?

Blood cells, molecules &amp; diseases
2016

Iron metabolism and related genetic diseases: A cleared land, keeping mysteries.

Journal of hepatology
2015

Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes.

Journal of clinical and translational hepatology
2015

Iron chelation therapy to prevent the manifestations of aceruloplasminemia.

Neurology
2015

CD1 Mouse Retina Is Shielded From Iron Overload Caused by a High Iron Diet.

Investigative ophthalmology &amp; visual science
2015

Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.

Parkinsonism &amp; related disorders
2015

Iron-induced Local Complement Component 3 (C3) Up-regulation via Non-canonical Transforming Growth Factor (TGF)-β Signaling in the Retinal Pigment Epithelium.

The Journal of biological chemistry
2015

Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series.

Diabetic medicine : a journal of the British Diabetic Association
2014

Atypical case of Wilson's disease with psychotic onset, low 24 hour urine copper and the absence of Kayser-Fleischer rings.

Vojnosanitetski pregled
Ver todos os 140 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Aceruloplasminemia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Aceruloplasminemia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Unexplained Coexisting Injury of the Liver, Pancreas, and Brain.
    Gastroenterology· 2026· PMID 41500318mais citado
  2. [Neurodegeneration Associated with Metal Metabolism].
    Brain and nerve = Shinkei kenkyu no shinpo· 2025· PMID 40350635mais citado
  3. Teaching NeuroImage: Clinicoradiologic Clues in Aceruloplasminemia.
    Neurology· 2025· PMID 40513045mais citado
  4. Neurodegeneration With Brain Iron Accumulation and Ferroptosis Disorders in Children and Adults: An Imaging Review.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging· 2025· PMID 41320772mais citado
  5. Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases.
    Frontiers in physiology· 2025· PMID 40951640mais citado
  6. Aceruloplasminemia in two sisters: insights from dopaminergic imaging and a splice-site mutation.
    Acta Neurol Belg· 2025· PMID 41428183recente
  7. MRI R2* and quantitative susceptibility mapping in brain tissue with extreme iron overload.
    Eur Radiol Exp· 2025· PMID 40848176recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:48818(Orphanet)
  2. OMIM OMIM:604290(OMIM)
  3. MONDO:0011426(MONDO)
  4. GARD:9499(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q337604(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Aceruloplasminemia
Compêndio · Raras BR

Aceruloplasminemia

ORPHA:48818 · MONDO:0011426
Prevalência
<1 / 1 000 000
Herança
Autosomal recessive
CID-10
E83.1 · Doença do metabolismo do ferro
CID-11
Ensaios
1 ativos
Início
Adult, Elderly
Prevalência
0.1 (Japan)
MedGen
UMLS
C0878682
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades